Cargando…
One-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India
BACKGROUND: Biodegradable polymer drug-eluting stents (BP-DES) have shown to reduce restenosis rates and have low rates of stent thrombosis. The present postmarketing surveillance assessed 1-year clinical outcomes of patients who had received NeoHexa DES in real practice. AIM: To investigate 1-year...
Autores principales: | Jambunathan, Rajagopal, Basavanna, Dinesh, Vani, Preeti, Neuss, Malte, Janbandhu, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715581/ https://www.ncbi.nlm.nih.gov/pubmed/31523398 http://dx.doi.org/10.4330/wjc.v11.i8.200 |
Ejemplares similares
-
One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study
por: Jain, Rajendra Kumar, et al.
Publicado: (2016) -
Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis
por: Bil, Jacek, et al.
Publicado: (2015) -
Real-world five-year outcomes of FlexyRap(®) cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease
por: Garg, Nitish, et al.
Publicado: (2023) -
Polymer-free sirolimus-eluting stents in a large-scale all-comers population
por: Krackhardt, Florian, et al.
Publicado: (2017) -
48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent
por: Tyczynski, Maciej, et al.
Publicado: (2023)